Kawamura, Atsushi
Uojima, Haruki
Chuma, Makoto
Shao, Xue
Hidaka, Hisashi
Nakazawa, Takahide
Take, Akira
Sakaguchi, Yoshihiko
Numata, Kazushi
Kako, Makoto
Nozaki, Akito
Azuma, Shintaro
Horio, Kazue
Kusano, Chika
Atsuda, Koichiro
Article History
Received: 28 February 2022
Accepted: 5 August 2022
First Online: 23 August 2022
Declarations
:
: This study was approved by the Institutional Review Boards and Ethics Committees of all hospitals involved. The Kitasato University School of Medicine and Hospital Ethics Committee (CRB3180002, B20–253), Yokohama City University Clinical Research Review Committee (CRB318007, A210100017). The study was registered in the Japan Registry of Clinical Trials (jRCT ID: 1030210283). These data were previously collected under another study (UMIN ID: 000036625). The data were collected after each patient wrote informed consent for the treatment and written informed consent was obtained from all participants. All methods were performed in accordance with the relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests as defined by Nature Research, or other interests that might be perceived to influence the results and/or discussion reported in this paper.